Word

NANT CANCER VACCINE

Status

Pending

Status Code

645

Status Date

Thursday, February 15, 2024

Serial Number

97599709

Mark Type

4000

Filing Date

Tuesday, September 20, 2022

Trademark Owner History

Nant Holdings IP, LLC

Classifications

5 Pharmaceutical preparations and substances for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccine preparations; low-dose chemotherapeutics, low dose radiopharmaceutical preparations, and personalized neoepitope-targeted pharmaceutical preparations for medical use for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biological preparations, namely, cell-derived preparations, cell therapeutics, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapeutics, low-dose radiation therapeutics, antibodies, fusion proteins, peptide and cytokine biological preparations, vaccines, personalized neoepitope-based therapeutics, and natural killer cell derived preparations, for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases, and cancer for clinical, medicinal, therapeutic, and veterinary purposes; kits containing pharmaceutical preparations and instructions, for treatment or preventative purposes

"CANCER VACCINE"

Trademark Events

Feb 15, 2024

Notification Of Final Refusal Emailed

Feb 15, 2024

Final Refusal E-Mailed

Feb 15, 2024

Final Refusal Written

Nov 21, 2023

Teas/Email Correspondence Entered

Nov 21, 2023

Correspondence Received In Law Office

Nov 21, 2023

Teas Response To Office Action Received

Aug 21, 2023

Notification Of Non-Final Action E-Mailed

Aug 21, 2023

Non-Final Action E-Mailed

Aug 21, 2023

Non-Final Action Written

Jun 29, 2023

Assigned To Examiner

Sep 26, 2022

New Application Office Supplied Data Entered

Sep 23, 2022

New Application Entered